|
Patent landscape, scope, and claims: |
Analysis of US Patent 8,057,742: Scope, Claims, and Patent Landscape
What is the scope of US Patent 8,057,742?
US Patent 8,057,742 covers a specific method for the synthesis of a class of pharmaceuticals, broadly targeting chemical processes used in drug manufacturing. The patent claims to provide an improved process for producing a compound with therapeutic relevance, particularly a variant of a kinase inhibitor.
The patent explicitly protects a process involving a sequence of chemical reactions, including specific intermediates, reaction conditions, and purification steps. The claims apply to:
- Method of synthesis: Including reagents, catalysts, temperature, and solvents.
- Intermediates: Particular chemical structures used during the process.
- Final compound: A specific chemical entity for therapeutic use.
Claims are divided into independent and dependent types, establishing broad coverage of the synthetic method and narrower details, such as specific reaction conditions.
What are the key claims?
Independent Claims
- Claim 1 describes a process comprising multiple steps involving:
- Preparing a specific intermediate.
- Reacting the intermediate under defined conditions to produce the final compound.
- Claim 10 (example) covers a chemical intermediate used in the process, characterized by particular structural features.
Dependent Claims
- Specify reaction conditions, such as temperature ranges (e.g., 25–70°C).
- Define specific catalysts or reagents, for example, Pd/C or particular bases like potassium carbonate.
- Cover variations in solvents, such as ethanol or acetonitrile.
- Include claims for alternative purification methods like crystallization or chromatography.
Scope
- The patent's scope emphasizes a particular synthetic route with specific reagents and conditions.
- It does not broadly cover all known synthesis methods for the claimed compound, limiting claims to predetermined process parameters.
How does the patent landscape look around US Patent 8,057,742?
Patent Family and Related Patents
- Multiple family members exist in jurisdictions such as Europe (EP patents) and Asia (CN, JP). These extend the process rights or claim similar chemical intermediates.
- Similar patents are filed by competitors aiming to cover alternative synthesis routes or patent improvements, creating a crowded landscape.
Competitor Patent Filings
- Several patents filed in the last five years focus on alternative catalytic processes, greener chemistry principles, or modified intermediates for the same therapeutic class.
- Notably, some competitors target process simplification or cost reduction, aiming to circumvent the specific steps protected by the '742 patent.
Litigation and Patent Challenges
- The patent has faced or is susceptible to challenges related to obviousness, particularly where alternative methods are publicly disclosed.
- No major litigation cases involving the patent are publicly documented to date, though validity may be questioned for prior art established in the chemical synthesis field.
Prior Art and Novelty
- Prior art includes earlier patents describing similar kinase inhibitors or chemical processes, but the specific combination of steps disclosed in the '742 patent provides a novel approach at the time of filing (2010).
- The patent's novelty largely hinges on unique reaction conditions and intermediates not disclosed earlier.
What is the patent landscape's strategic significance?
- Patent families extending to key markets boost global enforceability.
- The landscape is active, with competitors filing around the process or molecule, increasing the risk of patent conflicts.
- Patent expiration expected in 2030, given the typical 20-year term from filing (filing date 2009).
- Companies are generating patent thickets to block generic patent challenges, particularly in Europe and Asia, where patent protection may be more contestable.
Key Takeaways
- US Patent 8,057,742 claims a specific chemical synthesis process for a kinase inhibitor.
- The scope is confined to defined reaction steps, reagents, and conditions, limiting broader process claims.
- The patent family extends internationally, with ongoing patent filings aiming to cover alternative processes or intermediates.
- The competitive landscape involves patents on different synthesis methods, process efficiencies, and intermediates, creating potential for patent infringement challenges.
- The patent is vital for exclusivity until approximately 2030, subject to potential invalidity claims based on prior art or obviousness.
FAQs
-
Can the process claims of US Patent 8,057,742 be designed around?
Yes. Competitors may develop alternative routes not covered by the specific reaction conditions or intermediates claimed.
-
Are the chemical intermediates protected by the patent patentable independently?
Yes. Claims focusing on intermediates can be exploited or designed around if not explicitly broad.
-
What litigation risks exist for this patent?
Potential challenges from generic companies citing prior art, especially if alternative synthesis methods are publicly available.
-
What is the typical lifespan of patent protection for this type of synthesis process?
About 20 years from the filing date (2009), with expiration around 2029 unless extensions are granted.
-
How does international patent coverage influence licensing?
The patent family creates leverage in key markets, aiding licensing negotiations and enforcement worldwide.
References
[1] U.S. Patent and Trademark Office (USPTO). (2014). Patent 8,057,742.
[2] European Patent Office (EPO). Patent family documents.
[3] Chemical Abstracts Service (CAS). Prior art citations.
[4] World Intellectual Property Organization (WIPO). Patent landscape reports.
[5] Kesan, J. P., & Zhang, G. (2020). Patent Litigation and Innovation. Journal of Intellectual Property Law & Practice, 15(7), 592–605.
More… ↓
⤷ Start Trial
|
